[go: up one dir, main page]

AR047155A1 - METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA - Google Patents

METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA

Info

Publication number
AR047155A1
AR047155A1 ARP040104760A ARP040104760A AR047155A1 AR 047155 A1 AR047155 A1 AR 047155A1 AR P040104760 A ARP040104760 A AR P040104760A AR P040104760 A ARP040104760 A AR P040104760A AR 047155 A1 AR047155 A1 AR 047155A1
Authority
AR
Argentina
Prior art keywords
solid dosage
preparation
dosage form
desmopresin
pharmaceutically acceptable
Prior art date
Application number
ARP040104760A
Other languages
English (en)
Inventor
Kristina Wannerberger
Hans Lindner
Lars-Erik Olsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34560171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR047155(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of AR047155A1 publication Critical patent/AR047155A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Método para la preparacion de una forma de dosificacion solida de desmopresina, o una sal farmacéuticamente aceptable de la misma, el cual comprende proporcionar un granulado que contiene desmopresina adecuado para comprimirse hasta formar una tableta farmacéuticamente aceptable, así como a formas de dosificacion solidas, de preferencia tabletas, que se pueden obtener mediante este método.
ARP040104760A 2003-12-29 2004-12-17 METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA AR047155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (en) 2003-12-29 2003-12-29 Method for preparing a solid dosage form of desmopressin

Publications (1)

Publication Number Publication Date
AR047155A1 true AR047155A1 (es) 2006-01-11

Family

ID=34560171

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104760A AR047155A1 (es) 2003-12-29 2004-12-17 METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA

Country Status (11)

Country Link
EP (1) EP1550439B1 (es)
AR (1) AR047155A1 (es)
AT (1) ATE319430T1 (es)
DE (1) DE60303872T2 (es)
DK (1) DK1550439T3 (es)
ES (1) ES2254858T3 (es)
IL (3) IL165780A0 (es)
NO (1) NO20045657L (es)
PT (1) PT1550439E (es)
SI (1) SI1550439T1 (es)
TW (1) TWI282284B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2584456C (en) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
CA2724653A1 (en) 2008-05-21 2009-11-26 Ferring International Center S.A. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018602A1 (en) * 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)
MXPA04003540A (es) * 2001-10-15 2004-07-22 R Hm Gmbh & Co Kg Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.
DE60307082T4 (de) * 2002-05-07 2015-04-30 Ferring B.V. In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin

Also Published As

Publication number Publication date
DE60303872T2 (de) 2006-10-19
ES2254858T3 (es) 2006-06-16
NO20045657L (no) 2005-06-30
DE60303872D1 (de) 2006-05-04
IL202881A0 (en) 2011-07-31
DK1550439T3 (da) 2006-04-03
EP1550439A1 (en) 2005-07-06
PT1550439E (pt) 2006-06-30
NO20045657D0 (no) 2004-12-27
IL165780A0 (en) 2006-01-15
SI1550439T1 (sl) 2006-08-31
TWI282284B (en) 2007-06-11
IL189107A0 (en) 2008-06-05
HK1079696A1 (en) 2006-04-13
ATE319430T1 (de) 2006-03-15
TW200528141A (en) 2005-09-01
EP1550439B1 (en) 2006-03-08

Similar Documents

Publication Publication Date Title
CL2008003298A1 (es) Forma de dosificacion oral solida que comprende a) un compuesto de accion doble en concentracion entre 4 y 90%, b) un excipiente farmaceuticamente aceptable; proceso de preparación; uso en el tratamiento de enfermedades cardiovasculares y/o renales.
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
MX2007009162A (es) Formas de dosis rsistente al alcohol.
ECSP088188A (es) Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
TWI449540B (en) Process for the production of an abuse-proofed dosage form
CR9253A (es) Fijacion de la dosificacion de anticuerpos her
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
UY32153A (es) Inhibidores de piridomidinona de pi13ka(alfa) y mtor
EP2132013A4 (en) THIN METAL NANODRESSES MANUFACTURED BY BIOTEMPLATING
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
CR11013A (es) Forma de dosificacion novedosa
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
AR047155A1 (es) METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
ITMI20030341A1 (it) Sistema per controllare la fabbricazione di una molla.
EA200970816A1 (ru) Новая лекарственная форма
CL2004000984A1 (es) Forma de dosificacion oral de una sal de magnesio de (s)-pantopazol, para la profilaxis o tratamiento de una condicion asociada a inhibir la bomba protonica.
ITBO20040014A1 (it) Macchina comprimitrice per la produzione di compresse
WO2006123243A3 (en) Pharmaceutical dosage forms comprising escitalopram in form of granules
IS8185A (is) Aðferð til þess að búa til afleiður spíróbenzóazepíns sem eru ekki setnar með peptíði
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
UY28677A1 (es) Método para la preparación de una forma de dosificación sólida de desmopresina
EA201200727A1 (ru) Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения

Legal Events

Date Code Title Description
FA Abandonment or withdrawal